Impact of Visceral Fat on Survival and Metastasis of Stage III Colorectal Cancer
Open Access
- 28 July 2021
- journal article
- research article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 16 (1) , 53-61
Abstract
Jung Won Park, Soo Yeon Chang, Joon Seok Lim, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Won Ho Kim, and Tae Il Kim. Gut and Liver 2022;16:53-61. https://doi.org/10.5009/gnl20266Keywords
Funding Information
- Ministry of Health and Welfare, Republic of Korea (1631020)
- Asian Pacific Digestive Week 2018 (APDW 2018)
This publication has 33 references indexed in Scilit:
- Obesity and cancer risk: evidence, mechanisms, and recommendationsAnnals of the New York Academy of Sciences, 2012
- Obesity and Colorectal CancerClinics in Colon and Rectal Surgery, 2011
- Visceral adiposity, insulin resistance and cancer riskDiabetology & Metabolic Syndrome, 2011
- Different Adipose Depots: Their Role in the Development of Metabolic Syndrome and Mitochondrial Response to Hypolipidemic AgentsJournal of Obesity, 2011
- Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancerGut, 2009
- Visceral Obesity Predicts Surgical Outcomes after Laparoscopic Colectomy for Sigmoid Colon CancerDiseases of the Colon & Rectum, 2008
- Plasma C‐peptide, insulin‐like growth factor‐I, insulin‐like growth factor binding proteins and risk of colorectal cancer in a nested case‐control study: The Japan public health center‐based prospective studyInternational Journal of Cancer, 2007
- Abdominal obesity and metabolic syndromeNature, 2006
- Obesity and cancer risk: the role of the insulin–IGF axisTrends in Endocrinology & Metabolism, 2006
- Visceral Fat Accumulation and Cardiovascular DiseaseObesity Research, 1995